Immunovant, Inc. ( IMVT) - Stock Earnings
IMVT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
IMVT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -110.6 million USD | — USD |
| 2026Q1 | -147.9 million USD | — USD |
| 2026Q2 | -153.2 million USD | 7.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IMVT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -259.3 million USD | — USD |
| 2025 | -413.8 million USD | — USD |
| 2026 | -505.6 million USD | — USD |
| 2026 Est. | — | — |
IMVT
Price: $27.83
52 week price:
Earnings Per Share: -2.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 791496
Market Capitalization: 6.9 billion